XERIS BIOPHARMA HOLDINGS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | — | — | $19.5M |
| FY2020 | $125.4M | $159.2M | $37.6M |
| FY2021 | $209.1M | $304.4M | $67.3M |
| FY2022 | $299.3M | $344.5M | $122.0M |
| FY2023 | $329.4M | $322.6M | $67.4M |
| FY2024 | $352.7M | $323.1M | $71.6M |
| FY2025 | $369.8M | $383.5M | $111.0M |